Simplifying the Complex

Cancer Research Reimagined

Giving Cancer Research Every Advantage

Innovative Infrastructure.  Innovative Applications.

Built outside the conventional structure of a traditional CRO, OncoBay was designed from the outset to provide an innovative, streamlined focus on the execution of immuno-oncology programs while minimizing unnecessary and inefficient redundancies of systems, processes, and workforce. With our precise focus, we can provide our clients a team of highly experienced professionals with specialization in complex, early-phase oncology trials. OncoBay continues to provide unparalleled technological and professional expertise to accelerate the development of immunotherapies.

Learn our Capabilities

Experience is Our Cornerstone

Our mission and vision are to support the industry in accelerating development timelines to positively impact the lives of people with cancer. To this end, our organization is comprises experienced leaders in clinical oncology who are dedicated to making a difference.  From individual team members on each project to the OncoBay leadership team, every component of our organization is committed to making an impact.  In partnership with our parent company, the Moffitt Cancer Center, we are able to provide unmatched expertise to patients and sponsors.

Meet our Leadership

Not Just Any CRO

OncoBay is a boutique CRO designed to provide responsive, custom-curated services to biopharma and biotech companies seeking to overcome the hurdles of immuno-oncology clinical development.  Comprehensive in our abilities, streamlined in our design, unrivaled in our expertise, and unbounded in our dedication to supporting drug developers in discovering cures for cancer, OncoBay provides our clients with quality results, greater speed, and unmatched value.

About Our Approach

The Latest News & Events

Take Advantage of OncoBay’s Innovative Approach


Submit a Request for Proposal

Submit Proposal

OncoBay is now Kapadi


Once three entities – OncoBay Clinical, Clinscience, and Exom Group s.r.l – now we stand as one, bringing forth a symphony of expertise and seamless operations. To celebrate our unity, we re-brand under the banner of Kapadi, and embark on a new chapter of exceptional service in oncology clinical research.

Kapadi is not just a name; it's a testament to our fusion. It signifies the our standing as a global CRO powerhouse committed to accelerating groundbreaking cancer therapies that uplift patients worldwide. From conceptualizing studies, navigating regulations, and analyzing data, we provide a comprehensive array of services designed to empower your oncology clinical trials.




This pop-up will auto-close in 10 seconds.

This will close in 5 seconds